PTGX
Protagonist TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
PTGX vs peer average
40/100
PTGX vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · D 2 · F 4
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
APGE is the first available peer comparator.
Similarly valued development-stage biotech where multiple expansion depends more on clinical and strategic milestone delivery than on current product revenue, though indication overlap is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PTGX
Protagonist Therapeutics
APGE
Peer
Grade
D
-
Momentum
76
-
Value
55
-
Sentiment
27
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Unrated
Grade position vs APGE
PTGX / APGE
Grade Position
Below peers
PTGX vs. peer average (D vs. C)
40/100
Momentum
76
-Value
55
-Sentiment
27
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PTGX
APGE is the first peer returned for this comparison set.